Sad demise of father of Sh Ansal Mohammad (CHQ Legal Committee & Convener AIGETOA Kerala)

With extreme grief, we bring to you the sad news of the demise of father of Sh Ansal Mohammad (CHQ Legal Committee & Convener AIGETOA Kerala) today at Patla, Kasaragod Kerala.

AIGETOA CHQ prays to the almighty to provide his family with sufficient strength and courage to tide over the crisis and for bearing this irreparable loss. We also pray so that the eternal soul rests in peace.

AIGETOA writes to CMD BSNL – Relaxation of passing criterion of JTO Phase-I Trainees or making all India gradation list without any restriction on passing marks

AIGETOA writes to CMD BSNL for relaxation of passing criterion of JTO Phase-I Trainees or making all India gradation list without any restriction on passing marks.

AIGETOA demand to relax the passing percentage of 50% for all the trainees and to make all India gradation list without any passing criterion in view of the facts mentioned below:

1] All trainees do not have physical book for preparation as limited books were available.

2] Trainees have already passed JE to JTO LICE exam which itself is a very tough exam to clear. Hence testing the competency to again by virtue of another exam is not at all required. Instead, these Phase-I marks should be used only to prepare the all-India gradation list required for further promotions from JTO to SDE. For preparation of the gradation list, there is no need to have any cut-off percentage of marks. Hence the criterion for obtaining cut-off percentage of marks must be removed.

3] New change of exam pattern through online with new latest syllabus is happening first time for such trainees. Hence to ask these trainees to attempt 100 questions in 90 minutes is too high and it must be rationalised by bringing the number of questions lower down.

Click here for letter

Update on Meeting of Management and Associations with LIC on GTI Premium:

Today Meeting with LIC took place on the premium for GTI renewal. AIGETOA was represented by Shri Ravi Shil Verma, All India Chairman and Shri Badri Kumar Mehta, Finance Secretary.

AIGETOA team categorically told LIC representative that since the number of claims this year is very less and also this year premium takes care of the losses made by LIC in 2021 due to Covid, now premium should be at Par with the 2019 rates and any increase beyond that is not at all acceptable. LIC representative informed that they will revet back after working on the inputs by BSNL. LIC team also requested for number of claims due to Covid deaths which will be provided by establishment section.

Further AIGETOA is already taking up with management with regard to taking over of this GTI by BSNL. This is an agenda point in the meeting with management for the formal meeting to be held in the first week of February. The discussion on this point shall be held in the agenda meeting with BSNL Management.

An Appeal from Mr. Debashish Ghosh, AIGETOA Member, SDE Kolkata TD

Children. Just reminiscence of this word brings to our minds the vivid picture of super-active, playful nature of the most beautiful gifts in this creation. But Alas ! There are unlucky few who are deprived of this basic capability of doing normal activities on their own.

Debosmita Ghosh, 12-year-old girl, is one such child who is wheel chair bound and does not have the ability to move her arms and legs due to a rare neuromuscular disease classified as Spinal muscular atrophy (SPA). In this disease, nerves of the anterior horn cells of the spinal cord degenerate leading to gross hypotonia and muscle wasting. This weakness in the muscles throughout the body arises various complications such as knee knocking, bending of spine, osteoporosis to name a few. Some of the problems have been overcome by undergoing scoliosis correction surgery for her spine, zoledronate infusion for maintaining bone density, Bipap support for regular sleep etc. Despite all the efforts, she is having 80% locomotor disability. Naturally, she is fully dependent on all activities of daily living including eating, dressing and basic hygiene.

Despite all this crippling circumstances, she is brilliant in her academics. She is class topper and won accolades in many Olympiad exams and abacus competitions. Also, she is a talented singer, good in elocution, story-telling and creative writing. She dreams to become a teacher or an astronomer.

Currently, her condition has been progressively deteriorating. Only proper medical intervention has the ability to not only delay the disease progression but at times, effect mild improvements.

Only drug that can stop progression of her disease and help regaining milestone is Risdipalm. She is receiving this drug from last two years under a compassionate use program by the drug manufacturing company. Being on treatment has helped her to have few improvements in motor activities. However, this program of Risdipalm will end by 2023. Stoppage of this drug may deteriorate her condition and push her health and life to uncertainty. Presently, she is under Dr Sanjukta De of Peerless Hospital, Kolkata.

Risdipalm is a DCGI approved only drug commercially available India. But, the drug, costing Rs 72 Lacs per year, is exorbitantly high and beyond the affordability of her parents Mr. Debashish Ghosh, an AIGETOA member with Kolkata TD and Mrs. Moumita Ghosh, an optometrist.

In order to support her for at least 15 years, we are compelled to raise at least Rs. 10 Cr through crowd funding platform impactguru.com. It may be noted that the donor will be eligible to receive tax benefit for 100% of the contributed amount under section 80G of Income Tax Act of India.

We are hoping with in this period, Government of India will come up with some solution to continue treatment support to our only child. We are continuing to appeal to Government of India as well. Therefore, we appeal to all to help in this enormous task by making contribution as per own convenience such that our child has fair opportunity to realize her dreams.

Link for donation: http://impactguru.com/s/aZ5T20

Prakram Diwas – 23rd Jan 2023